What is the medical term for recurrent hemopurulent abscesses or pustules?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hidradenitis Suppurativa

The medical term for recurrent hemopurulent (blood and pus-filled) abscesses or pustules is hidradenitis suppurativa (HS), also known as acne inversa.

Definition and Clinical Presentation

Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent nodules and abscesses that rupture and lead to sinus tracts (tunnels) and scarring 1. The condition primarily affects intertriginous areas—the axillae, inguinal and anogenital regions, and inframammary areas 1.

The key distinguishing features include:

  • Recurrent painful nodules that progress to abscesses
  • Hemopurulent drainage (mixture of blood and pus)
  • Tunnel formation (previously called sinus tracts or fistulas)
  • Scarring with chronic inflammation
  • Location: body folds and areas with apocrine glands

Important Distinction from Other Conditions

Do not confuse HS with simple recurrent abscesses or furunculosis. While recurrent abscesses at the same site may be caused by local factors such as foreign material, pilonidal cysts, or simple furunculosis 2, HS is a distinct chronic inflammatory disease with a different pathophysiology and treatment approach.

Key Differentiating Features:

Furunculosis (recurrent boils):

  • Hair follicle infections caused by S. aureus 3
  • Individual lesions that drain and heal
  • Typically respond to incision/drainage and decolonization strategies
  • Do not form tunnels or extensive scarring

Hidradenitis Suppurativa:

  • Chronic inflammatory disease of the hair follicle unit 1
  • Progressive with tunnel formation and architectural tissue changes
  • Requires systemic anti-inflammatory therapy
  • Associated with significant comorbidities (metabolic syndrome, inflammatory bowel disease, depression) 4, 5

Diagnostic Approach

The diagnosis is clinical—there are no pathognomonic laboratory tests 4. Look for:

  1. Typical lesion morphology: painful nodules, abscesses, draining tunnels
  2. Characteristic locations: axillae, groin, perianal, inframammary areas
  3. Recurrent pattern: at least 2 occurrences in 6 months
  4. Chronicity: lesions that persist or recur over time

Ultrasound imaging is emerging as a useful tool for assessing deep-seated lesions and tunnels that may not be apparent on surface examination 4.

Clinical Pitfalls

  • Diagnostic delay is common—patients often wait years before correct diagnosis 4
  • Do not label HS lesions as "cellulitis"—the primary treatment for HS is not antibiotics alone but requires anti-inflammatory therapy and often surgical intervention 2
  • Recurrent abscesses in the same location should prompt evaluation for HS, especially in intertriginous areas 2
  • Screen for comorbidities: metabolic syndrome, inflammatory bowel disease, depression, and polycystic ovarian syndrome are strongly associated 4, 5

Management Framework

Diagnosis should be made by a dermatologist or healthcare professional with expert knowledge in HS 1. Treatment is multimodal and depends on severity:

Mild Disease (Hurley Stage I):

  • Topical clindamycin 1% solution/gel twice daily for 12 weeks, OR
  • Tetracycline 500 mg orally twice daily for 4 months 1

Moderate-to-Severe Disease:

  • Clindamycin 300 mg orally twice daily with rifampin 600 mg orally once daily for 10 weeks 1
  • If inadequate response: Adalimumab (160 mg at week 0,80 mg at week 2, then 40 mg subcutaneously weekly) 1

Adjunctive Measures (All Patients):

  • Pain management
  • Weight loss counseling
  • Tobacco cessation
  • Treatment of superinfections
  • Appropriate wound dressings 1

Surgical intervention should be assessed in all patients depending on the extent of scarring and tunnel formation 1, 6.

Critical Point

The distinction between HS and simple recurrent abscesses is clinically crucial because the primary treatment differs fundamentally: simple abscesses require drainage with possible decolonization strategies 2, while HS requires chronic anti-inflammatory medical therapy, often combined with surgical intervention, to prevent progressive tissue destruction 1, 6, 5.

Related Questions

In a patient with a year-long history of recurrent right upper inner thigh abscesses, skin tethering, thickening, sinus tracts, and left groin lesions (no axillary involvement) currently on doxycycline, is this hidradenitis suppurativa and should a surgical consult be obtained?
Can you explain hidradenitis suppurativa, its causes, symptoms, and treatment options, as a doctor would to a patient?
What is the appropriate treatment for comedones (blackheads) in the inframammary area?
Can Hidradenitis Suppurativa (HS) present as a single lesion?
What is the management for a 45-year-old female patient with painful lesions on both axillae, a history of flares, and a diagnosis consistent with hidradenitis suppurativa?
How should I treat slowed speech (hypokinetic dysarthria) in a patient with Parkinson's disease?
What conservative treatment is recommended for a one‑month‑old infant with postoperative nerve entanglement?
What is the appropriate conservative (non‑surgical) treatment for a newborn infant with suspected necrotizing enterocolitis?
What is the recommended management of peritonitis in a 1‑month‑15‑day‑old infant?
For a research paper titled "Psychiatric comorbidity and its clinical specificity in fibromyalgia (FM): comparisons with low back pain (LBP)" within the scope of the P3 study, is it appropriate to use the International Classification of Diseases, 11th Revision (ICD‑11) criteria for diagnosing fibromyalgia (FM) and chronic low back pain (LBP), and are the Brief Pain Inventory – short form (BPI), the Toronto Alexithymia Scale (TAS‑20), and the Millon Clinical Multiaxial Inventory‑III (MCMI‑III) acceptable measurement tools?
What are the differences between esomeprazole and omeprazole?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.